The Company's products serve the Refractive Vision Correction, Cataract Treatment, and Glaucoma Treatment segments of the ophthalmic market. The Company's products are designed to improve treatment results, minimize patient risk and discomfort and, where possible, simplify ophthalmic procedures for the surgeon and the patient. The Company sells its products worldwide, principally to ophthalmologists, surgical centers, hospitals, managed care providers, health maintenance organizations and group purchasing organizations.
Revenues reflect unfavorable exchange rates.
Net loss suffered from decreased margins due to increased costs for the silicone IOL and higher marketing and selling commissions expenses. Market Guide offers more in-depth Company Research , Stock Screening , and Hottest Stocks and Industries on over 10,000 U.S. Equities. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Some event data provided by StreetEvents .